PUBLICATIONS

In vitro studies show synergistic effects of a procoagulant bispecific antibody and bypassing agents

No.40
Year2018
JournalJournal of Thrombosis and Haemostasis
InstituteShire
1st AuthorHartmann R
AR
PL
Paper typesBasic science
Main
purpose
Drug efficacy evaluation
DiseaseHemophilia A
Antiplatelet drug
Anticoagulant drug
Other drugemicizumab, aPCC, rFVIIa
Clinical specimens
Animal
KeywordBispecific antibody
PL Chip for T-TAS01 is available for in vitro diagnostic use only in the the United States and EU Copyright © 2020 FUJIMORI KOGYO CO.,LTD. All Rights Reserved.